- Current report filing (8-K)
September 13 2010 - 9:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 9, 2010
MICRUS ENDOVASCULAR CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-51323
|
|
23-2853441
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
821 Fox Lane, San Jose, California
|
|
95131
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including area code: (408) 433-1400
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM 8.01. OTHER EVENTS.
On September 9, 2010, Micrus Endovascular Corporation was informed that it had received approval from the People’s Republic of China State Food and Drug Administration (SFDA) to market its bare platinum, non-stretch resistant microcoils in China.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
MICRUS ENDOVASCULAR CORPORATION
|
|
|
|
|
Date: September 13, 2010
|
By:
|
/s/ Gordon T. Sangster
|
|
|
Name:
|
Gordon T. Sangster
|
|
|
Title:
|
Chief Financial Officer
|
Micrus Endovascular (MM) (NASDAQ:MEND)
Historical Stock Chart
From Jul 2024 to Aug 2024
Micrus Endovascular (MM) (NASDAQ:MEND)
Historical Stock Chart
From Aug 2023 to Aug 2024